Researchers found that the APOE4 gene, a major risk factor for Alzheimer’s disease, can lead to changes in the brain even before memory problems arise. In a study involving mice, scientists discovered that this gene increases the production of a protein called Nell2, which shrinks neurons and causes them to become hyperactive. This early hyperactivity is linked to worse memory later in life, suggesting that addressing these changes could help prevent or delay the onset of Alzheimer’s.

This discovery is significant for anyone concerned about aging and cognitive health, especially those who carry the APOE4 gene, which affects about one in four people. By targeting the effects of Nell2, there is potential for new treatments that could help maintain cognitive function and overall brain health. The ability to reverse the changes in neurons in adult mice raises hope for developing therapies that could intervene before Alzheimer’s symptoms manifest.

The research is still in its early stages, conducted in mouse models, and while the findings are promising, they have not yet been proven in humans. The study highlights a crucial link between genetic risk factors and brain function, providing a clearer understanding of how the APOE4 gene contributes to cognitive decline. As scientists continue to explore this pathway, there may be new opportunities for interventions that could benefit those at risk of Alzheimer’s disease.

For those interested in brain health, staying informed about genetic factors like APOE4 and maintaining a healthy lifestyle with regular exercise, a balanced diet, and mental stimulation could be beneficial steps while researchers work toward potential treatments.